Future directions should also consider developing a hybrid model or a tiered approach that combines PSA-based risk stratification with genetic screening, MRI, and other biomarkers to create an efficient, personalised pathway for early prostate cancer detection. Here, KLK3 is linked to prostate carcinoma.